An investigation on behalf of investors of AveXis, Inc. (NASDAQ: AVXS) in connection with the proposed takeover was announced.
San Diego, CA -- (SBWIRE) -- 04/19/2018 -- An investigation was announced for investors, who currently hold shares of AveXis, Inc. (NASDAQ: AVXS), over the takeover of AveXis, Inc.
Investors who purchased shares of AveXis, Inc. (NASDAQ: AVXS) and currently hold any of those NASDAQ: AVXS shares have certain options and should contact the Shareholders Foundation at email@example.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain officers and directors of AveXis, Inc. breached their fiduciary duties owed to NASDAQ: AVXS investors in connection with the proposed acquisition.
On April 09, 2018, AveXis, Inc. (NASDAQ:AVXS) announced that it has entered into an agreement and plan of merger with Novartis pursuant to which Novartis will acquire AveXis, Inc. for $218 per share or a total of $8.7 billion in cash.
However, the investigation concerns whether the offer is unfair to NASDAQ: AVXS stockholders. More specifically, the investigation concerns whether the AveXis Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders' best interests in connection with the proposed sale.
Shares of AveXis, Inc. (NASDAQ: AVXS) closed on April 18, 2018, at $209.60 per share.
Those who are current investors in AveXis, Inc. (NASDAQ: AVXS) shares have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
For more information on this press release visit:
Media Relations Contact
Email: Click to Email Michael Daniels